De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

Nature Communications

Volumn 4, Issue , 2013, Pages

  Eissing, Leah ^a   Scherer, Thomas ^b,f   Tödter, Klaus ^a   Knippschild, Uwe ^c   Greve, Jan Willem ^d   Buurman, Wim A ^e   Pinnschmidt, Hans O ^a   Rensen, Sander S ^e   Wolf, Anna M ^c   Bartelt, Alexander ^a   Heeren, Joerg ^a   Buettner, Christoph ^b   Scheja, Ludger ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d Sittard Geleen Heerlen   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN BETA; FAT; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER 4; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

CARBOHYDRATE; ENZYME ACTIVITY; FAT; FATTY ACID; GENE EXPRESSION; GLUCOSE; LIPID; METABOLISM; OBESITY; PROTEIN; RODENT;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPOGENESIS; LIVER; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN EXPRESSION; UPREGULATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSITY; ADULT; BARIATRIC SURGERY; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BODY MASS INDEX; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FATTY LIVER; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HEALTH; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPOGENESIS; LIVER; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; RNA, MESSENGER; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874600898     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2537     Document Type: Article

References (60)

1. Rosen, E. D. & Spiegelman, B. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853 (2006) (Pubitemid 46024991)
2. Virtue, S. & Vidal-Puig, A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim. Biophys. Acta. 1801, 338-349 (2010)
3. Farese, Jr R. V., Zechne, r, R., Newgard, C. B. & Walther, T. C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 15, 570-573 (2012)
4. Cao, H. et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944 (2008)
5. Huo, Y. et al. Targeted overexpression of inducible 6-phosphofructo-2- kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses. J. Biol. Chem. 287, 21492-21500 (2012)
6. Yang, Z. H., Miyahara, H. & Hatanaka, A. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 10, 120 (2011)
7. Guo, X. et al. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. PLoS One 7, e39286 (2012)
8. Postic, C. & Girard, J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118, 829-838 (2008) (Pubitemid 351364588)
9. Chavez, J. A. & Summers, S. A. A ceramide-centric view of insulin resistance. Cell Metab. 15, 585-594 (2012)
10. Fessler, M. B., Rudel, L. L. & Brown, J. M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr. Opin. Lipidol. 20, 379-385 (2009)
11. Wu, M. et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc. Natl Acad. Sci. USA 108, 5378-5383 (2011)
12. Camastra, S. et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 54, 2093-2102 (2011)
13. van Dielen, F. M., Buurman, W. A., Hadfoune, M., Nijhuis, J. & Greve, J. W. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J. Clin. Endocrinol. Metab. 89, 4062-4068 (2004) (Pubitemid 39071514)
14. Dixon, J. B. & O'Brien, P. E. Lipid profile in the severely obese, changes with weight loss after lap-band surgery. Obes. Res. 10, 903-910 (2002) (Pubitemid 135688904)
15. Dixon, J. B., Bhathal, P. S., Hughes, N. R. & O'Brien, P. E. Nonalcoholic fatty liver disease, Improvement in liver histological analysis with weight loss. Hepatology 39, 1647-1654 (2004) (Pubitemid 38702666)
16. Faraj, M. et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 88, 1594-1602 (2003) (Pubitemid 36623375)
17. Sarruf, D. A., Bonner-Weir, S. & Schwartz, M. W. New clues to bariatric surgery's benefits. Nat. Med. 18, 860-861 (2012)
18. Hellerstein, M. K., Schwarz, J. M. & Neese, R. A. Regulation of hepatic de novo lipogenesis in humans. Annu. Rev. Nutr. 16, 523-557 (1996) (Pubitemid 26286864)
19. Enoch, H. G., Catala, A. & Strittmatter, P. Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J. Biol. Chem. 251, 5095-5103 (1976)
20. Moon, Y. A., Shah, N. A., Mohapatra, S., Warrington, J. A. & Horton, J. D. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element binding proteins. J. Biol. Chem. 276, 45358-45366 (2001)
21. Garvey, W. T. et al. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulindependent diabetes mellitus and obesity. J. Clin. Invest. 87, 1072-1081 (1991)
22. Yamashita, H. et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl Acad. Sci. USA 98, 9116-9121 (2001) (Pubitemid 32743878)
23. Herman, M. A. et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484, 333-338 (2012)
24. Després, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006) (Pubitemid 46024995)
25. Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14, 15-19 (2003) (Pubitemid 36183096)
26. Pardina, E. et al. Only C-reactive protein, but not TNF-a or IL6, reflects the improvement in inflammation after bariatric surgery. Obes. Surg. 22, 131-139 (2012)
27. Ortega, F. J. et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity 18, 13-20 (2010)
28. Diraison, F., Dusserre, E., Vidal, H., Sothier, M. & Beylot, M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am. J. Physiol. Endocrinol. Metab. 282, E46-E51 (2002) (Pubitemid 34654105)
29. Hudgins, L. C. et al. The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects. J. Nutr. Biochem. 19, 237-245 (2008) (Pubitemid 351312274)
30. Richardson, D. K. & Czech, M. P. Diminished activities of fatty acid synthesis enzymes in insulin-resistant adipocytes from spontaneously obese rats. Horm. Metab. Res. 11, 427-431 (1979) (Pubitemid 9239380)
31. Nadler, S. T. et al. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl Acad. Sci. USA 97, 11371-11376 (2000)
32. Kouidhi, S. et al. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Acta. Diabetol. (e-pub ahead of print 22May 2011)
33. Abel, E. D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733 (2001) (Pubitemid 32144519)
34. Hurtado del Pozo, C. et al. ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity. Biochim. Biophys. Acta. 1811, 1194-1200 (2011)
35. Stanhope, K. L. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119, 1322-1334 (2009)
36. Peter, A. et al. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J. Clin. Endocrinol. Metab. 96, E1126-E1130 (2011)
37. Roberts, R. et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52, 882-890 (2009)
38. Gong, J. et al. Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine? Am. J. Clin. Nutr. 93, 186-191 (2011)
39. Chavez, J. A. & Summers, S. A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419, 101-109 (2003) (Pubitemid 37329976)
40. Hommelberg, P. P., Plat, J., Langen, R. C., Schols, A. M. & Mensink, R. P. Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent. Am. J. Physiol. Endocrinol. Metab. 296, E114-E120 (2009)
41. van den Berg, S. A. et al. High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity. Nutr. Metab. 7, 24 (2010)
42. Liu, X. et al. Loss of stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler. Thromb. Vasc. Biol. 30, 31-38 (2010)
43. Stefan, N. et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 33, 405-407 (2010)
44. Fabbrini, E. et al. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J. Lipid Res. 52, 808-812 (2011)
45. Pinnick, K. E. et al. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 61, 1399-1403 (2012)
46. Yli-Jama, P. et al. Selective mobilisation of fatty acids from human adipose tissue. Eur. J. Intern. Med. 12, 107-115 (2001) (Pubitemid 32294292)
47. Faix, D. et al. Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. J. Lipid Res. 34, 2063-2075 (1993) (Pubitemid 24000955)
48. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D. & Parks, E. J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351 (2005) (Pubitemid 40629054)
49. Benhamed, F. et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 122, 2176-2194 (2012)
50. Dentin, R. et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55, 2159-2170 (2006) (Pubitemid 44743612)
51. Knebel, B. et al. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass. PLoS One 7, e31812 (2012)
52. Matsuzaka, T. et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat. Med. 13, 1193-1202 (2007) (Pubitemid 47530641)
53. Erbay, E. et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med. 15, 1383-1391 (2009)
54. Maedler, K. et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52, 726-733 (2003) (Pubitemid 36323580)
55. Green, C. D. & Olson, L. K. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic b-cells by stearoyl-CoA desaturase and Elovl6. Am. J. Physiol. Endocrinol. Metab. 300, E640-E649 (2011)
56. Flowers, J. B. et al. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56, 1228-1239 (2007) (Pubitemid 46715602)
57. Scherer, T. et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183-194 (2011)
58. Scheja, L. et al. Liver TAG transiently decreases while PL n-3 and n-6 fatty acids are persistently elevated in insulin resistant mice. Lipids 43, 1039-1051 (2008)
59. Kleinbaum, D. G. & Klein, M. Logistic Regression: A Self-Learning Text (Springer, 2005)
60. Pierce, C. A., Block, R. A. & Aguinis, H. Cautionary note on reporting eta-squared values from multifactor ANOVA designs. Educ. Psychol. Meas. 64, 916-924 (2004). (Pubitemid 39604741)